TSRX is so cheap with an excellent MRSA killer on the way!!! BUY before train leaves!!!!!!!!!!!!!!!!!!!!!!!!
MRSA is huge problem, we will likely have fast-track status from Gain Act (read seeking alpha June 27 story). Tedizolid kills some MRSA strains resistant to Zyvox. Look through the presentations and papers listed on the TSRX website. Don't wait too long to buy this very cheap company with a new MRSA assassin. Tedizolid kills in 6 days, what Zyvox takes 10 days to kill. This is huge!!
TSRX was incorporated in 2004, that's eight years.
Have they produced any commercial product in those eight years?
I question how much income will be derived from Ted, and whether the income will be shared with big pharma, or in the case of a buyout what pps we would derive?
TSRX is a great investment at these levels. In a few month you'll wish you had been buying here. In response to you question there are several estimates out there and the ultimate PPS is mid to low teens. GL